文献速递泌尿生殖腹部MR

双参数前列腺MRI与临床指标预测PSA灰区男性临床显著前列腺癌

Biparametric prostate MRI and clinical indicators predict clinically significant prostate cancer in men with "gray zone" PSA levels.
PubMed 文献 · Eur J Radiol · 2020-04-10

回顾性分析364例PSA灰区(4-10 ng/mL)且经病理确诊的男性,随机分为训练组255例和验证组109例,用双参数MRI的PI-RADS v2评分与临床指标建立预测模型。训练组中PI-RADS v2评分和前列腺体积为独立预测因子,联合模型AUC大于其他单一预测因子,诊断敏感度84.1%、特异度83.4%,验证组预测性能更好。

要点

  • PSA灰区(4-10 ng/mL)男性中,双参数MRI的PI-RADS v2评分是临床显著前列腺癌最强的单变量预测因子。
  • PI-RADS v2评分联合前列腺体积的预测模型AUC大于其他单一预测因子,训练组敏感度84.1%、特异度83.4%。
  • 该预测模型在验证组中显示更好的预测性能,对PSA灰区男性临床显著前列腺癌有满意预测价值。

核心结论

  • 基于双参数MRI的PI-RADS v2评分联合前列腺体积的预测模型对PSA灰区(4-10 ng/mL)男性临床显著前列腺癌具有满意预测价值。
  • PI-RADS v2评分是PSA灰区男性检出临床显著前列腺癌最强的单变量预测因子,联合前列腺体积可提供更优预测能力。

研究设计与样本

  • 回顾性分析2015年1月至2019年10月364例PSA灰区(4-10 ng/mL)升高、经病理确诊且接受MRI检查的患者,随机分为训练组255例和验证组109例。
  • 对训练组行多变量逻辑回归分析识别临床显著前列腺癌的独立预测因子并建立预测模型,在训练组和验证组中通过ROC曲线评估模型。

诊断标准与关键数值

  • 训练组中PI-RADS v2评分和前列腺体积为临床显著前列腺癌的独立预测因子(P < 0.05)。
  • 由PI-RADS v2评分和前列腺体积构成的预测模型在训练组中AUC大于其他单一预测因子。
  • 预测模型诊断敏感度为84.1%、特异度为83.4%。

临床应用与阅片要点

  • 在PSA灰区(4-10 ng/mL)男性中,可依据双参数MRI的PI-RADS v2评分联合前列腺体积的预测模型评估临床显著前列腺癌风险。
  • 该预测模型在验证组中显示更好的预测性能,原文结论认为其对该人群临床显著前列腺癌具有满意预测价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To predict clinically significant prostate cancer (cs-PCa) by combining the Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) score based on biparametric magnetic resonance imaging (bp-MRI) and clinical indicators in men with prostate-specific antigen (PSA) levels in the gray zone of 4-10 ng/mL.

METHOD: We retrospectively analyzed 364 patients with elevated PSA levels in the gray zone who had pathologically confirmed disease and had undergone MRI examinations from January 2015 to October 2019; a training group (n = 255) and validation group (n = 109) were randomly established. Multivariate logistic regression analysis of the training group was performed to identify the independent predictors for cs-PCa, thereby establishing a predictive model that was evaluated in the training and validation groups by analyzing the receiver operating characteristic (ROC) curve.

RESULTS: In the training group, the PI-RADS v2 score and prostate volume (PV) were independent predictors of cs-PCa (P < 0.05). The prediction model comprising the PI-RADS v2 score and PV had a larger AUC than the other predictors alone in the training group. The diagnostic sensitivity and specificity of the prediction model were 84.1 % and 83.4 %, respectively. The prediction model was indicated to have better predictive performance in the validation group.

CONCLUSIONS: The prediction model exhibits a satisfactory predictive value for cs-PCa in men with PSA levels in the gray zone. PI-RADS v2 is the strongest univariate predictor for the detection of cs-PCa in men with PSA in the gray zone, but combining this with the PV can provide superior predictive ability.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Wei CG, Chen T, Zhang YY, et al. Biparametric prostate MRI and clinical indicators predict clinically significant prostate cancer in men with "gray zone" PSA levels. Eur J Radiol. 2020. PMID: 32330776. doi:10.1016/j.ejrad.2020.108977

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。